Current situation of proton therapy for Hodgkin lymphoma: from expectations to evidence

P Loap, A Mirandola, L De Marzi, R Dendale, A Iannalfi… - Cancers, 2021 - mdpi.com
Simple Summary Hodgkin lymphoma (HL) is a highly curable disease; in this context, the
limitation of late adverse events is of prime importance for the patient. Proton therapy for …

Function-Wise Dual-Omics analysis for radiation pneumonitis prediction in lung cancer patients

B Li, G Ren, W Guo, J Zhang, SK Lam… - Frontiers in …, 2022 - frontiersin.org
Purpose: This study investigates the impact of lung function on radiation pneumonitis
prediction using a dual-omics analysis method. Methods: We retrospectively collected data …

Radiation-induced esophagitis in non-small-cell lung cancer patients: voxel-based analysis and NTCP modeling

S Monti, T Xu, R Mohan, Z Liao, G Palma, L Cella - Cancers, 2022 - mdpi.com
Simple Summary Radiation-induced esophagitis (RE) is a common dose-limiting
complication associated with concurrent chemoradiation therapy for Non-Small-Cell Lung …

Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy

M Chen, Z Wang, S Jiang, J Sun, L Wang, N Sahoo… - Scientific reports, 2022 - nature.com
This study aimed to compare the predictive performance of different modeling methods in
developing normal tissue complication probability (NTCP) models for predicting radiation …

Combined deep learning and radiomics in pretreatment radiation esophagitis prediction for patients with esophageal cancer underwent volumetric modulated arc …

C Xie, X Yu, N Tan, J Zhang, W Su, W Ni, C Li… - Radiotherapy and …, 2024 - Elsevier
Purpose To develop a combined radiomics and deep learning (DL) model in predicting
radiation esophagitis (RE) of a grade≥ 2 for patients with esophageal cancer (EC) …

Substantial sparing of organs at risk with modern proton therapy in lung cancer, but altered breathing patterns can jeopardize target coverage

CG Boer, K Fjellanger, IM Sandvik, M Ugland… - Cancers, 2022 - mdpi.com
Simple Summary Treatment of locally advanced non-small cell lung cancer (LA-NSCLC) is a
fine balance between toxicity and cure. Modern proton therapy might offer a more gentle …

Proton Therapy in Breast Cancer: A Review of Potential Approaches for Patient Selection

XY Wu, M Chen, L Cao, M Li… - Technology in Cancer …, 2024 - journals.sagepub.com
Proton radiotherapy may be a compelling technical option for the treatment of breast cancer
due to its unique physical property known as the “Bragg peak.” This feature offers distinct …

Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer

A Köthe, N Bizzocchi, S Safai, AJ Lomax, DC Weber… - Radiation …, 2021 - Springer
Background Hypoxia is known to be prevalent in solid tumors such as non-small cell lung
cancer (NSCLC) and reportedly correlates with poor prognostic clinical outcome. PET …

Improving Prediction of Complications Post-Proton Therapy in Lung Cancer Using Large Language Models and Meta-Analysis

PJ Chao, CH Chang, JJ Wu, YH Liu, J Shiau… - Cancer …, 2024 - journals.sagepub.com
Purpose This study enhances the efficiency of predicting complications in lung cancer
patients receiving proton therapy by utilizing large language models (LLMs) and meta …

[HTML][HTML] The impact of organ motion and the appliance of mitigation strategies on the effectiveness of hypoxia-guided proton therapy for non-small cell lung cancer

A Köthe, AJ Lomax, AC Giovannelli, S Safai… - Radiotherapy and …, 2022 - Elsevier
Abstract Background and Purpose To investigate the impact of organ motion on hypoxia-
guided proton therapy treatments for non-small cell lung cancer (NSCLC) patients. Materials …